Delivery Order SPE2DE21D0022-SPE2D626F826M
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $1,598.58 fixed-price delivery order to Dove Medical Supply LLC on August 7, 2025, for FLU/RSV/SARS-CoV-2 positive control materials. The contract, which carries an ultimate completion date of September 5, 2025, represents a non-set-aside competitive award to the Summerfield, North Carolina-based vendor. This delivery order is issued under Dove Medical Supply LLC's existing $400 million Indefinite Delivery/Indefinite Quantity contract...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,450 delivery order to Dove Medical Supply LLC, a minority-owned, woman-owned small disadvantaged business based in Summerfield, North Carolina, on August 1, 2025. The contract, with an ultimate completion date of August 29, 2025, is for FLU/RSV/SARS-CoV-2 positive control materials used in diagnostic testing and quality assurance processes. This delivery order utilizes fixed-price pricing with economic price adjustment terms and...
- The U.S. Department of Defense awarded a $1,598.58 fixed-price delivery order with economic price adjustment to Dove Medical Supply LLC for FLU/RSV/SARS-CoV-2 positive control materials. The award, issued on December 8, 2025, is scheduled for completion by January 7, 2026, and represents a non-competitive procurement through the Medical Supply Chain program. Dove Medical Supply LLC, a minority-owned and woman-owned small disadvantaged business based in Summerfield, North Carolina, was selected...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,065.72 to Dove Medical Supply LLC on August 13, 2025, for the provision of FLU/RSV/SARS-COV-2 positive control materials. The contract, which operates under a fixed-price model with economic price adjustment provisions, is scheduled for completion by September 11, 2025, and will be performed at the vendor's facility in Summerfield, North Carolina. This delivery order was awarded without set-aside...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order valued at $1,065.72 to Dove Medical Supply LLC for FLU/RSV/SARS-CoV-2 positive control materials on November 14, 2025, with an ultimate completion date of December 15, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and was awarded without a set-aside designation. Dove Medical Supply LLC, a minority-owned and woman-owned small disadvantaged business based...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order valued at $1,065.72 to Dove Medical Supply LLC for FLU/RSV/SARS-CoV-2 positive control materials. The contract is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of October 6, 2025. This award was made without a set-aside designation, demonstrating the contractor's competitive capability in open federal procurement. Dove Medical Supply LLC, a...
- The U.S. Department of Defense awarded a delivery order valued at $1,308.58 to Dove Medical Supply LLC on December 8, 2025, for the provision of FLU/RSV/SARS-CoV-2 negative control materials. The contract is fixed price with economic price adjustment and is scheduled for completion by January 7, 2026. Dove Medical Supply LLC, a minority-owned, woman-owned small disadvantaged business based in Summerfield, North Carolina, will perform the work at its location in Summerfield, NC. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,551.44 fixed-price delivery order to Dove Medical Supply LLC on December 5, 2025, for FLU/RSV/SARS-CoV-2 negative control materials. The contract, which is non-set-aside and due for completion by January 6, 2026, will be performed in Summerfield, North Carolina. This delivery order is issued under Dove Medical Supply LLC's existing $400 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract (SPE2DE21D0022) with the...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $15,985.80 fixed-price delivery order (SPE2DE21D0022) to Dove Medical Supply LLC, a minority-owned, woman-owned small disadvantaged business. The order is for the procurement of FLU/RSV/SARS-COV-2 positive control products. This delivery order is part of a larger $400 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract (SPE2DE21D0022) that Dove Medical Supply holds with the DLA Troop Support Medical....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order (Contract No. 4567267430) valued at $1,065.72 to Dove Medical Supply LLC on February 13, 2025, with an ultimate completion date of March 14, 2025. This fixed-price delivery order with economic price adjustment is for FLU/RSV/SARS-CoV-2 positive control materials, which serve as quality assurance and validation tools for diagnostic testing. The award was made through a non-set-aside competitive procurement process to the...
- SPE2DE21D0022Indefinite Delivery Contract
- SPE2DE21D0022-SPE2D626F826MDelivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a fixed-price delivery order valued at $1,065.72 to Dove Medical Supply LLC on December 5, 2025, for the provision of FLU/RSV/SARS-CoV-2 positive control materials. The contract, which is not set-aside, will be completed by January 6, 2026, with performance taking place in Summerfield, North Carolina. This delivery order is issued under Dove Medical Supply LLC's existing $400 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract (SPE2DE21D0022) established with DLA Troop Support Medical in September 2021, which provides the company authority to supply a comprehensive range of laboratory and medical products to the Department of Defense and other federal agencies. Dove Medical Supply LLC is a minority-owned, woman-owned small disadvantaged business that specializes in providing medical and laboratory supplies to federal agencies. The company has demonstrated significant capability in competing for federal procurements, with a diverse portfolio of medical products including diagnostic test kits, laboratory equipment, reagents, and quality control materials. This particular delivery order for positive control materials supports critical diagnostic testing capabilities within the federal medical supply chain, aligning with the company's established role as a key vendor for infectious disease diagnostic products and laboratory supplies across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/4/25 |